Rifampin-induced Pseudomembranous Colitis with Rectosigmoid Sparing |
Yim, Sun-Young
(Department of Internal Medicine, Korea University College of Medicine)
Koo, Ja-Seol (Department of Internal Medicine, Korea University College of Medicine) Kim, Ye-Ji (Department of Internal Medicine, Korea University College of Medicine) Park, Sang-Jung (Department of Internal Medicine, Korea University College of Medicine) Kim, Jin-Nam (Department of Internal Medicine, Inje University Seoul Paik Hospital, Inje University College of Medicine) Jung, Sung-Woo (Department of Internal Medicine, Korea University College of Medicine) Yim, Hyung-Joon (Department of Internal Medicine, Korea University College of Medicine) Lee, Sang-Woo (Department of Internal Medicine, Korea University College of Medicine) Choi, Jai-Hyun (Department of Internal Medicine, Korea University College of Medicine) Kim, Chang-Duck (Department of Internal Medicine, Korea University College of Medicine) |
1 | Rubesin SE, Levine MS, Glick SN, Herlinger H, Laufer I. Pseudomembranous colitis with rectosigmoid sparing on barium studies. Radiology 1989;170:811-813. DOI |
2 | Bartlett JG. Clinical practice. Antibiotic-associated diarrhea. N Engl J Med 2002;346:334-339. DOI ScienceOn |
3 | Jung SW, Jeon SW, Do BH, et al. Clinical aspects of rifampicin-associated pseudomembranous colitis. J Clin Gastroenterol 2007;41:38-40. DOI ScienceOn |
4 | Chen TC, Lu PL, Lin WR, Lin CY, Wu JY, Chen YH. Rifampin-associated pseudomembranous colitis. Am J Med Sci 2009;338:156-158. DOI ScienceOn |
5 | Akbar DH, Al-Shehri HZ, Al-Huzali AM, Falatah HI. A case of rifampicin induced pseudomembraneous colitis. Saudi Med J 2003;24:1391-1393. |
6 | Moriarty HJ, Scobie BA. Pseudomembranous colitis in a patient on rifampicin and ethambutol. N Z Med J 1980;91:294-295. |
7 | Klaui H, Leuenberger P. Pseudomembranous colitis due to rifampicin. Lancet 1981;2:1294. |
8 | George RH. Pseudomembranous colitis probably due to rifampicin. Lancet 1980;1:1304. |
9 | Park JY, Kim JS, Jeung SJ, Kim MS, Kim SC. A case of pseudomembranous colitis associated with rifampin. Korean J Intern Med 2004;19: 261-265. DOI |
10 | Nakajima A, Yajima S, Shirakura T, et al. Rifampicin-associated pseudomembranous colitis. J Gastroenterol 2000;35:299-303. DOI ScienceOn |
11 | Barbut F, DecrbuD, Burghoffer B, et al. Antimicrobial susceptibilities and serogroups of clinical strains of Clostridium difficile isolated in France in 1991 and 1997. Antimicrob Agents Chemother 1999;43:2607-2611. |
12 | Bendle JS, James PA, Bennett PM, Avison MB, Macgowan AP, Al-Shafi KM. Resistance determinants in strains of Clostridium difficile from two geographically distinct populations. Int J Antimicrob Agents 2004; 24:619-621. DOI ScienceOn |
13 | LaHatte LJ, Schuman BM. Antibiotic-associated injury to the gut. In: Haubrich WS, Schaffner F, Berk JE, eds. Bockus Gastroenterology. 5th ed. Philadelphia: WB Saunders; 1995. p. 1657-1671. |
14 | Fournier G, Orgiazzi J, Lenoir B, Dechavanne M. Pseudomembranous colitis probably due to rifampicin. Lancet 1980;1:101. |
15 | Woo ML, Cho JH, Kim JH, et al. Anti-tuberculosis agents induced Pseudomembranous colitis treated with maintaining anti-tuberculosis drugs. Korean J Gastrointest Endosc 2009;38:47-51. |
16 | Burbige EJ, Radigan JJ. Antibiotic-associated colitis with normal-appearing rectum. Dis Colon Rectum 1981;24:198-200. DOI ScienceOn |
17 | Tedesco FJ, Corless JK, Brownstein RE. Rectal sparing in antibiotic-associated pseudomembranous colitis: a prospective study. Gastroenterology 1982;83:1259-1260. |
18 | Gonenne J, Pardi DS. Clostridium difficile: an update. Compr Ther 2004; 30:134-140. |
![]() |